ANTIMICROBIAL EFFECTS OF TEA-TREE OIL AND ITS MAJOR COMPONENTS ON STAPHYLOCOCCUS-AUREUS, STAPHYLOCOCCUS-EPIDERMIDIS AND PROPIONIBACTERIUM-ACNES

被引:147
作者
RAMAN, A
WEIR, U
BLOOMFIELD, SF
机构
[1] Department of Pharmacy, King's College London, London
关键词
D O I
10.1111/j.1472-765X.1995.tb01051.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Major components of two tea-tree oil samples were identified using thin layer and gas-liquid chromatography (TLC and GLC). Using a TLC-bioautographic technique, the tea-tree oils, terpinen-4-ol, alpha-terpineol and alpha-pinene were found to be active against Staphylococcus aureus Staph. epidermidis and Propionibacterium (acnes whereas cineole was inactive against these organisms. The MIC values of the three active compounds increased in the order alpha-terpineol < terpinen-4-ol < alpha-pinene for all three micro-organisms, MIC values of the tea-tree oils and terpinen-4-ol were lower for P. acnes than for the two staphylococci. This study supports the use of tea-tree oil in the treatment of acne, and demonstrates that terpinen-4-ol is not the sole active constituent of the oil.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 8 条
[1]   A COMPARATIVE-STUDY OF TEA-TREE OIL VERSUS BENZOYLPEROXIDE IN THE TREATMENT OF ACNE [J].
BASSETT, IB ;
PANNOWITZ, DL ;
BARNETSON, RS .
MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 (08) :455-&
[2]  
BOYD RF, 1991, BASIC MED MICROBIOLO, P400
[3]   ANTIMICROBIAL ACTIVITY OF THE ESSENTIAL OIL OF MELALEUCA-ALTERNIFOLIA [J].
CARSON, CF ;
RILEY, TV .
LETTERS IN APPLIED MICROBIOLOGY, 1993, 16 (02) :49-55
[4]   SUSCEPTIBILITY OF PROPIONIBACTERIUM-ACNES TO THE ESSENTIAL OIL OF MELALEUCA-ALTERNIFOLIA [J].
CARSON, CF ;
RILEY, TV .
LETTERS IN APPLIED MICROBIOLOGY, 1994, 19 (01) :24-25
[5]  
DRURY S, 1991, TEA TREE OIL, P43
[6]   MELALEUCA OIL (TEA TREE OIL) DERMATITIS [J].
KNIGHT, TE ;
HAUSEN, BM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (03) :423-427
[7]  
SHANSON DC, 1989, MICROBIOLOGY CLIN PR, P382
[8]  
WILLIAMS LR, 1988, INT J AROMATHERAPY, V1, P13